Top IBD therapies by cost 2014
This statistic displays the costs of the top inflammatory bowel disease drugs worldwide as of 2014. During this time, Janssen Biotech's Remicade, a therapy targeting Crohn's disease and ulcerative collitis costs 31,856 U.S. dollars for the first-year regimen. Approximately, 1 to 1.3 million people currently suffer from IBD in the United States, however, the cause of IBD is currently unknown. IBD occurs in the colon and intestine and can also impact other parts of the body.
